• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Electroconvulsive therapy and subsequent epilepsy in patients with affective disorders: A register-based Danish cohort study
Conclusion In patients with affective disorders, we found a weak positive association between ECT and subsequent diagnosis of epilepsy in those younger than 40 years, and a weak negative association in patients older than 60 years. The associations might be subject to residual confounding from risk factors related to ECT.
Source: Brain Stimulation - December 6, 2017 Category: Neurology Source Type: research

The Use of Ultrabrief Left Unilateral Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and Right-Sided Encephalomalacia and Stroke: A Case Report
No abstract available
Source: The Journal of ECT - December 1, 2017 Category: Psychiatry Tags: Letters to the Editor Source Type: research

Electroconvulsive therapy and risk of epilepsy in patients with affective disorders: A register-based Danish cohort study
Conclusion In patients with affective disorders, we found a weak positive association between ECT and subsequent diagnosis of epilepsy in those younger than 40 years, and a weak negative association in patients older than 60 years. The associations might be subject to residual confounding from risk factors related to ECT treatment.
Source: Brain Stimulation - November 27, 2017 Category: Neurology Source Type: research

Low medical morbidity and mortality after acute courses of electroconvulsive therapy in a population ‐based sample
ConclusionMorbidity and mortality events after ECT treatments were relatively low, supporting ECT as a low‐risk medical procedure.
Source: Acta Psychiatrica Scandinavica - September 18, 2017 Category: Psychiatry Authors: D. M. Blumberger, D. P. Seitz, N. Herrmann, J. G. Kirkham, R. Ng, C. Reimer, P. Kurdyak, A. Gruneir, M. J. Rapoport, Z. J. Daskalakis, B. H. Mulsant, S. N. Vigod Tags: Original Article Source Type: research

Mind the Treatment Gap
getty images/ istock photoBy Vani S. Kulkarni and Raghav GaihaPHILADELPHIA AND NEW DELHI, Apr 14 2017 (IPS)Implementation of the Mental Healthcare Act will require a restructuring of health-care services The Mental Healthcare Bill, 2016, which was passed in the Lok Sabha on March 27, 2017, has been hailed as a momentous reform. According to the Bill, every person will have the right to access mental health care operated or funded by the government; good quality and affordable health care; equality of treatment and protection from inhuman practices; access to legal services; and right to complain against coercion and cruelt...
Source: IPS Inter Press Service - Health - April 14, 2017 Category: Global & Universal Authors: Vani Kulkarni and Raghav Gaiha Tags: Asia-Pacific Development & Aid Gender Gender Violence Headlines Health Human Rights Women's Health Source Type: news

Ketamine Therapy for Treatment-resistant Depression in a Patient with Multiple Sclerosis: A Case Report
Conclusion—Ketamine may be an alternative treatment for resistant depression and may have a special use in patients with multiple sclerosis. Introduction Depression is a frequent finding in patients with multiple sclerosis (MS), with the lifetime prevalence rates for major depressive disorder (MDD) ranging from 36 to 54 percent, more than twice of that in the general population.[1] Even with advances in pharmacological options for treating depression, an estimated 33 to 66 percent of patients with MDD in the general population do not respond to the first antidepressant, and a reported 15 to 33 percent of patients do not ...
Source: Innovations in Clinical Neuroscience - February 1, 2017 Category: Neuroscience Authors: ICN Online Editor Tags: Case Report Current Issue Depression Multiple Sclerosis Neurology Psychiatry Psychopharmacology Electroconvulsive therapy Ketamine major depressive disorder treatment-resistant depression Source Type: research

Beat Depression to Stay Healthier & Live Longer: A Guide for Older Adults & Their Families
Many people find the reality of getting older depressing. And depression itself often comes with a stigma. So when we talk about depression and aging combined, what results is a very complicated — and often hard to treat — issue. Gary S. Moak, former president of the American Association for Geriatric Psychiatry, has written a new book to help. Beat Depression to Stay Healthier and Live Longer: A Guide for Older Adults and Their Families combines Moak’s years of experience working with elderly populations with the latest research on depression. Moak begins by defining depression and clarifying many of the myths...
Source: Psych Central - January 28, 2016 Category: Psychiatry Authors: Claire Nana Tags: Aging Antidepressants Book Reviews Depression Family General Psychology Self-Help Seniors Treatment antidepressants for elderly patients antidepressants for old people beat depression depression and aging depression geriatric Source Type: news

Electroconvulsive Therapy in a Patient With Moyamoya Syndrome
We report on a 30-year-old woman diagnosed with moyamoya syndrome resulting from sickle cell disease who developed catatonia and was successfully treated with electroconvulsive therapy (ECT). Neuroimaging revealed severe tandem narrowing of the left internal carotid artery with diminished cerebral blood flow, moderate narrowing of the right supraclinoid aspect of the right internal carotid artery, and associated numerous lenticulostriate collaterals bilaterally, consistent with moyamoya. The patient presented with mutism; posturing; immobility; stupor; withdrawal; refusal to eat, drink, or speak; and staring, supporting a ...
Source: The Journal of ECT - February 21, 2015 Category: Psychiatry Tags: Case Reports Source Type: research

Applications of transcranial magnetic stimulation and magnetic seizure therapy in the study and treatment of disorders related to cerebral aging.
Authors: Luber B, McClintock SM, Lisanby SH Abstract Transcranial magnetic stimulation (TMS) can be used to probe cortical function and treat neuropsychiatric illnesses. TMS has demonstrated neuroplastic effects akin to long-term potentiation and long-term depression, and therapeutic applications are in development for post-stroke recovery, Alzheimer's disease, and depression in seniors. Here, we discuss two new directions of TMS research relevant to cerebral aging and cognition. First, we introduce a paradigm for enhancing cognitive reserve, based on our research in sleep deprivation. Second, we discuss the use of...
Source: Dialogues in Clinical Neuroscience - November 12, 2014 Category: Neuroscience Tags: Dialogues Clin Neurosci Source Type: research

Safety of Noninvasive Brain Stimulation in Children and Adolescents
Conclusion Our findings indicate that both repetitive TMS and tCS are safe modalities in children and adolescents with various neurological conditions, especially when safety guidelines are followed. The incidence of adverse events appears to be similar to that observed in adults; however, further studies with longer treatment and follow-up periods are needed to better understand the benefits and tolerance of long-term use of NIBS in children.
Source: Brain Stimulation - November 4, 2014 Category: Neurology Source Type: research

Post-Stroke Depression Therapy: Where are we Now?
Abstract Post-stroke depression is an important psychological consequence of ischemic stroke, and affects around one third of stroke patients at any time post-stroke. It has a negative impact on patient morbidity and mortality, and as such development of effective post-stroke recognition and treatment strategies are very important. There are several therapeutic strategies for post-stroke depression, including both pharmacological and non-pharmacological approaches. In this review, we present evidence regarding the underlying biology of post-stroke depression, commonalities between post-stroke depression and Major ...
Source: Current Neurovascular Research - May 22, 2014 Category: Neurology Authors: Nabavi SF, Turner A, Dean OM, Sureda A, Nabavi SM Tags: Curr Neurovasc Res Source Type: research

Pages: 1  2